Office of Research & Development |
|
Project Number: | I01BX006279-01 |
Title: | ERK-Signaling in Microenvironment of Pancreatic cancer: Development of NovelTherapeutic Hypoxia-Responsive Nano-encapsulated ERK inhibitor |
Principal Investigator: | Sushanta K. Banerjee |
Location: | Kansas City, MO |
Congressional District Code: | 5 |
Research Service: | Biomedical Laboratory R&D |
Project Period: | January 2024 - December 2027 |
FY 2025 Funding Amount: | $209,000 |
Abstract: |
View abstract and other project information on NIH RePORTER Go To NIH RePORTER |